Register free now:

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Register  

Markers for COVID-19: Comprehensive LC-MS characterization of the metabolome

Available On-Demand

LinkedIn icon

During this webinar you’ll learn about the recently launched Xevo G3 QTof system and discover how its solving problems that matter.

Professor Clare Mills discusses the use of an LC/MS metabolomics approach to profile serum from COVID-19 inpatients. Here they describe how to identify and characterize prognostic biomarkers to support the development of mass spectrometry rapid clinical screening tools.

Tune in to hear more about how the team are planning to characterize immune disfunction as a consequence of SARS-CoV-2 infection.

Key learning objectives

  • Discover how the new Xevo G3 QTof system provides comprehensive characterization of analytes.
  • Develop an understanding of LC/MS and its use in metabolomic and lipidomic studies.
  • Delve into the world of omics, identifying statistically relevant markers for disease and the impact on patients.

Who should attend?

  • Scientists interested in characterizing a range of analytes with LC/MS.
  • Lab managers who want high-throughput, benchtop QTof technology that helps solve problems in their lab.

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

            

Speakers:

Presenter
Clare Mills
Professor of molecular allergology
University of Manchester
View Biography
Presenter
Dr Jayne Kirk
Principal Product Manager
Waters Corporation
View Biography
Presenter
Dr. Carrie Haslam
Associate Editor
SelectScience
View Biography